Appendix 1: Tuberculosis in Canada 2012 – Data tables
Appendix 1: Data tables
| Main diagnostic site | Reporting year | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | |||
|
|||||||||||||
| Respiratory | PrimaryTable 9 - Footnote * | Cases | 88 | 79 | 94 | 106 | 91 | 64 | 59 | 61 | 63 | 48 | 59 |
| Rate | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | ||
| PulmonaryTable 9 - Footnote ** | Cases | 1,052 | 992 | 965 | 982 | 1,132 | 1,034 | 1,147 | 1,126 | 1,042 | 1,098 | 1,138 | |
| Rate | 3.4 | 3.1 | 3.0 | 3.0 | 3.5 | 3.1 | 3.4 | 3.3 | 3.1 | 3.2 | 3.3 | ||
| Other respiratoryTable 9 - Footnote ^ | Cases | 53 | 63 | 90 | 113 | 85 | 94 | 78 | 97 | 102 | 83 | 97 | |
| Rate | 0.2 | 0.2 | 0.3 | 0.4 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | 0.2 | 0.3 | ||
| Nonrespiratory | Miliary | Cases | 9 | 12 | 14 | 15 | 10 | 11 | 14 | 12 | 11 | 13 | 8 |
| Rate | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| CNS | Cases | 18 | 26 | 19 | 20 | 16 | 22 | 11 | 14 | 24 | 21 | 21 | |
| Rate | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | ||
| Peripheral lymph nodes | Cases | 240 | 247 | 251 | 242 | 192 | 202 | 182 | 207 | 198 | 220 | 204 | |
| Rate | 0.8 | 0.8 | 0.8 | 0.8 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | ||
| OtherTable 9 - Footnote ^^ | Cases | 177 | 169 | 179 | 162 | 127 | 148 | 153 | 138 | 147 | 135 | 158 | |
| Rate | 0.6 | 0.5 | 0.6 | 0.5 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | ||
| Unknown | Cases | 30 | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Rate | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| TOTAL | Cases | 1,667 | 1,631 | 1,612 | 1,640 | 1,653 | 1,575 | 1,644 | 1,655 | 1,587 | 1,618 | 1,685 | |
| Rate | 5.3 | 5.2 | 5.0 | 5.1 | 5.1 | 4.8 | 4.9 | 4.9 | 4.7 | 4.7 | 4.8 | ||
| Main diagnostic site | Canada | Province/territory | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N.L. | P.E.I. | N.S. | N.B. | Que. | Ont. | Man. | Sask. | Alta. | B.C. | Y.T. | N.W.T. | Nvt. | ||||
|
||||||||||||||||
| Respiratory | PrimaryTable 10-1 - Footnote * | Cases | 63 | 0 | 0 | 1 | 2 | 2 | 9 | 8 | 17 | 5 | 3 | 0 | 4 | 12 |
| Rate | 0.2 | 0.0 | 0.0 | 0.1 | 0.3 | 0.0 | 0.1 | 0.6 | 1.6 | 0.1 | 0.1 | 0.0 | 9.1 | 36.6 | ||
| PulmonaryTable 10-1 - Footnote ** | Cases | 1,042 | 7 | 0 | 5 | 6 | 151 | 405 | 88 | 50 | 74 | 173 | 6 | 4 | 73 | |
| Rate | 3.1 | 1.4 | 0.0 | 0.5 | 0.8 | 1.9 | 3.1 | 7.1 | 4.8 | 2.0 | 3.8 | 17.3 | 9.1 | 222.4 | ||
| Other respiratoryTable 10-1 - Footnote ^ | Cases | 102 | 0 | 1 | 0 | 0 | 11 | 40 | 9 | 7 | 12 | 11 | 0 | 0 | 11 | |
| Rate | 0.3 | 0.0 | 0.7 | 0.0 | 0.0 | 0.1 | 0.3 | 0.7 | 0.7 | 0.3 | 0.2 | 0.0 | 0.0 | 33.5 | ||
| Nonrespiratory | Miliary | Cases | 11 | 0 | 0 | 1 | 0 | 1 | 4 | 2 | 0 | 1 | 1 | 0 | 1 | 0 |
| Rate | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 | 0.0 | ||
| CNS | Cases | 24 | 0 | 0 | 0 | 0 | 4 | 13 | 1 | 1 | 0 | 3 | 0 | 1 | 1 | |
| Rate | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 2.3 | 3.0 | ||
| Peripheral lymph nodes | Cases | 198 | 0 | 0 | 1 | 1 | 20 | 98 | 13 | 5 | 26 | 34 | 0 | 0 | 0 | |
| Rate | 0.6 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.7 | 1.1 | 0.5 | 0.7 | 0.8 | 0.0 | 0.0 | 0.0 | ||
| OtherTable 10-1 - Footnote ^^ | Cases | 147 | 1 | 0 | 2 | 1 | 21 | 74 | 11 | 1 | 16 | 16 | 0 | 1 | 3 | |
| Rate | 0.4 | 0.2 | 0.0 | 0.2 | 0.1 | 0.3 | 0.6 | 0.9 | 0.1 | 0.4 | 0.4 | 0.0 | 2.3 | 9.1 | ||
| Unknown | Cases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Rate | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| TOTAL | Cases | 1,587 | 8 | 1 | 10 | 10 | 210 | 643 | 132 | 81 | 134 | 241 | 6 | 11 | 100 | |
| Rate | 4.7 | 1.6 | 0.7 | 1.1 | 1.3 | 2.7 | 4.9 | 10.7 | 7.8 | 3.6 | 5.3 | 17.3 | 25.1 | 304.7 | ||
| Main diagnostic site | Canada | Province/territory | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N.L. | P.E.I. | N.S. | N.B. | Que. | Ont. | Man. | Sask. | Alta. | B.C. | Y.T. | N.W.T. | Nvt. | ||||
|
||||||||||||||||
| Respiratory | PrimaryTable 10-2 - Footnote * | Cases | 48 | 2 | 0 | 3 | 0 | 1 | 13 | 7 | 13 | 2 | 1 | 0 | 0 | 6 |
| Rate | 0.1 | 0.4 | 0.0 | 0.3 | 0.0 | 0.0 | 0.1 | 0.6 | 1.2 | 0.1 | 0.0 | 0.0 | 0.0 | 17.9 | ||
| PulmonaryTable 10-2 - Footnote ** | Cases | 1,098 | 5 | 3 | 5 | 3 | 162 | 420 | 79 | 51 | 98 | 197 | 2 | 9 | 64 | |
| Rate | 3.2 | 1.0 | 2.1 | 0.5 | 0.4 | 2.0 | 3.1 | 6.3 | 4.8 | 2.6 | 4.3 | 5.7 | 20.4 | 190.8 | ||
| Other respiratoryTable 10-2 - Footnote ^ | Cases | 83 | 0 | 0 | 0 | 0 | 8 | 35 | 9 | 5 | 17 | 8 | 0 | 0 | 1 | |
| Rate | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.7 | 0.5 | 0.4 | 0.2 | 0.0 | 0.0 | 3.0 | ||
| Nonrespiratory | Miliary | Cases | 13 | 0 | 0 | 0 | 0 | 1 | 4 | 1 | 1 | 1 | 5 | 0 | 0 | 0 |
| Rate | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | ||
| CNS | Cases | 21 | 0 | 0 | 0 | 0 | 1 | 14 | 1 | 1 | 3 | 1 | 0 | 0 | 0 | |
| Rate | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Peripheral lymph nodes | Cases | 220 | 1 | 0 | 0 | 0 | 32 | 106 | 15 | 8 | 27 | 29 | 1 | 1 | 0 | |
| Rate | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.4 | 0.8 | 1.2 | 0.8 | 0.7 | 0.6 | 2.8 | 2.3 | 0.0 | ||
| OtherTable 10-2 - Footnote ^^ | Cases | 135 | 0 | 0 | 1 | 2 | 12 | 66 | 4 | 4 | 22 | 17 | 1 | 3 | 3 | |
| Rate | 0.4 | 0.0 | 0.0 | 0.1 | 0.3 | 0.2 | 0.5 | 0.3 | 0.4 | 0.6 | 0.4 | 2.8 | 6.8 | 8.9 | ||
| Unknown | Cases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Rate | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| TOTAL | Cases | 1,618 | 8 | 3 | 9 | 5 | 217 | 658 | 116 | 83 | 170 | 258 | 4 | 13 | 74 | |
| Rate | 4.7 | 1.6 | 2.1 | 0.9 | 0.7 | 2.7 | 4.9 | 9.3 | 7.8 | 4.5 | 5.6 | 11.3 | 29.4 | 220.6 | ||
| Main diagnostic site | Canada | Province/territory | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N.L. | P.E.I. | N.S. | N.B. | Que. | Ont. | Man. | Sask. | Alta. | B.C. | Y.T. | N.W.T. | Nvt. | ||||
|
||||||||||||||||
| Respiratory | PrimaryTable 10-3 - Footnote * | Cases | 59 | 0 | 1 | 3 | 2 | 8 | 5 | 8 | 11 | 12 | 3 | 0 | 0 | 6 |
| Rate | 0.2 | 0.0 | 0.7 | 0.3 | 0.3 | 0.1 | 0.0 | 0.6 | 1.0 | 0.3 | 0.1 | 0.0 | 0.0 | 17.8 | ||
| PulmonaryTable 10-3 - Footnote ** | Cases | 1138 | 4 | 0 | 4 | 3 | 207 | 365 | 97 | 54 | 116 | 216 | 1 | 4 | 67 | |
| Rate | 3.3 | 0.8 | 0.0 | 0.4 | 0.4 | 2.6 | 2.7 | 7.7 | 5.0 | 3.0 | 4.7 | 2.8 | 9.2 | 198.8 | ||
| Other respiratoryTable 10-3 - Footnote ^ | Cases | 97 | 0 | 0 | 0 | 0 | 11 | 26 | 13 | 7 | 18 | 15 | 0 | 1 | 6 | |
| Rate | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 1.0 | 0.6 | 0.5 | 0.3 | 0.0 | 2.3 | 17.8 | ||
| Nonrespiratory | Miliary | Cases | 8 | 0 | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 1 | 2 | 0 | 0 | 0 |
| Rate | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| CNS | Cases | 21 | 0 | 0 | 0 | 0 | 1 | 14 | 1 | 3 | 2 | 0 | 0 | 0 | 0 | |
| Rate | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Peripheral lymph nodes | Cases | 204 | 0 | 0 | 1 | 0 | 16 | 116 | 11 | 5 | 32 | 23 | 0 | 0 | 0 | |
| Rate | 0.6 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | 0.9 | 0.9 | 0.5 | 0.8 | 0.5 | 0.0 | 0.0 | 0.0 | ||
| OtherTable 10-3 - Footnote ^^ | Cases | 158 | 0 | 0 | 0 | 0 | 21 | 79 | 7 | 11 | 15 | 24 | 0 | 1 | 0 | |
| Rate | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.6 | 0.6 | 1.0 | 0.4 | 0.5 | 0.0 | 2.3 | 0.0 | ||
| Unknown | Cases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Rate | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| TOTAL | Cases | 1685 | 4 | 1 | 8 | 5 | 266 | 608 | 137 | 91 | 196 | 283 | 1 | 6 | 79 | |
| Rate | 4.8 | 0.8 | 0.7 | 0.8 | 0.7 | 3.3 | 4.5 | 10.8 | 8.4 | 5.1 | 6.1 | 2.8 | 13.8 | 234.4 | ||
| Age group | Total | Main diagnostic site | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | Nonrespiratory | Unknown | ||||||||
| PrimaryTable 11-1 - Footnote * | PulmonaryTable 11-1 - Footnote ** | Other respiratoryTable 11-1 - Footnote ^ | Miliary | CNS | Peripheral lymph nodes | OtherTable 11-1 - Footnote ^^ | ||||
|
||||||||||
| <1 | Cases | 9 | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Rate | 2.4 | 2.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1-4 | Cases | 27 | 17 | 6 | 0 | 0 | 1 | 2 | 1 | 0 |
| Rate | 1.8 | 1.1 | 0.4 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | |
| 5-14 | Cases | 39 | 14 | 16 | 2 | 2 | 0 | 2 | 3 | 0 |
| Rate | 1.0 | 0.4 | 0.4 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | |
| 15-24 | Cases | 201 | 7 | 138 | 19 | 1 | 0 | 23 | 13 | 0 |
| Rate | 4.4 | 0.2 | 3.0 | 0.4 | 0.0 | 0.0 | 0.5 | 0.3 | 0.0 | |
| 25-34 | Cases | 282 | 3 | 168 | 20 | 0 | 3 | 63 | 25 | 0 |
| Rate | 6.0 | 0.1 | 3.6 | 0.4 | 0.0 | 0.1 | 1.3 | 0.5 | 0.0 | |
| 35-44 | Cases | 273 | 4 | 174 | 14 | 2 | 6 | 38 | 35 | 0 |
| Rate | 5.8 | 0.1 | 3.7 | 0.3 | 0.0 | 0.1 | 0.8 | 0.7 | 0.0 | |
| 45-54 | Cases | 214 | 6 | 137 | 12 | 1 | 6 | 36 | 16 | 0 |
| Rate | 4.0 | 0.1 | 2.5 | 0.2 | 0.0 | 0.1 | 0.7 | 0.3 | 0.0 | |
| 55-64 | Cases | 176 | 2 | 122 | 9 | 1 | 4 | 16 | 22 | 0 |
| Rate | 4.1 | 0.0 | 2.9 | 0.2 | 0.0 | 0.1 | 0.4 | 0.5 | 0.0 | |
| 65-74 | Cases | 149 | 1 | 108 | 11 | 2 | 3 | 5 | 19 | 0 |
| Rate | 5.8 | 0.0 | 4.2 | 0.4 | 0.1 | 0.1 | 0.2 | 0.7 | 0.0 | |
| 75+ | Cases | 217 | 1 | 172 | 15 | 2 | 1 | 13 | 13 | 0 |
| Rate | 9.6 | 0.0 | 7.6 | 0.7 | 0.1 | 0.0 | 0.6 | 0.6 | 0.0 | |
| TOTAL | Cases | 1,587 | 63 | 1,042 | 102 | 11 | 24 | 198 | 147 | 0 |
| Rate | 4.7 | 0.2 | 3.1 | 0.3 | 0.0 | 0.1 | 0.6 | 0.4 | 0.0 | |
| Age group | Total | Main diagnostic site | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | Nonrespiratory | Unknown | ||||||||
| PrimaryTable 11-2 - Footnote * | PulmonaryTable 11-2 - Footnote ** | Other respiratoryTable 11-2 - Footnote ^ | Miliary | CNS | Peripheral lymph nodes | OtherTable 11-2 - Footnote ^^ | ||||
|
||||||||||
| <1 | Cases | 14 | 6 | 6 | 0 | 1 | 0 | 0 | 1 | 0 |
| Rate | 3.7 | 1.6 | 1.6 | 0.0 | 0.3 | 0.0 | 0.0 | 0.3 | 0.0 | |
| 1-4 | Cases | 33 | 16 | 16 | 0 | 0 | 0 | 1 | 0 | 0 |
| Rate | 2.2 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
| 5-14 | Cases | 40 | 11 | 18 | 1 | 0 | 1 | 5 | 4 | 0 |
| Rate | 1.1 | 0.3 | 0.5 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | |
| 15-24 | Cases | 216 | 3 | 162 | 12 | 0 | 3 | 22 | 14 | 0 |
| Rate | 4.7 | 0.1 | 3.5 | 0.3 | 0.0 | 0.1 | 0.5 | 0.3 | 0.0 | |
| 25-34 | Cases | 296 | 3 | 184 | 17 | 1 | 2 | 65 | 24 | 0 |
| Rate | 6.2 | 0.1 | 3.9 | 0.4 | 0.0 | 0.0 | 1.4 | 0.5 | 0.0 | |
| 35-44 | Cases | 251 | 0 | 156 | 19 | 1 | 8 | 51 | 16 | 0 |
| Rate | 5.4 | 0.0 | 3.3 | 0.4 | 0.0 | 0.2 | 1.1 | 0.3 | 0.0 | |
| 45-54 | Cases | 224 | 2 | 153 | 9 | 3 | 1 | 30 | 26 | 0 |
| Rate | 4.1 | 0.0 | 2.8 | 0.2 | 0.1 | 0.0 | 0.6 | 0.5 | 0.0 | |
| 55-64 | Cases | 166 | 1 | 113 | 8 | 2 | 0 | 24 | 18 | 0 |
| Rate | 3.8 | 0.0 | 2.6 | 0.2 | 0.0 | 0.0 | 0.5 | 0.4 | 0.0 | |
| 65-74 | Cases | 172 | 2 | 121 | 12 | 2 | 4 | 16 | 15 | 0 |
| Rate | 6.4 | 0.1 | 4.5 | 0.4 | 0.1 | 0.1 | 0.6 | 0.6 | 0.0 | |
| 75+ | Cases | 206 | 4 | 169 | 5 | 3 | 2 | 6 | 17 | 0 |
| Rate | 8.9 | 0.2 | 7.3 | 0.2 | 0.1 | 0.1 | 0.3 | 0.7 | 0.0 | |
| TOTAL | Cases | 1,618 | 48 | 1,098 | 83 | 13 | 21 | 220 | 135 | 0 |
| Rate | 4.7 | 0.1 | 3.2 | 0.2 | 0.0 | 0.1 | 0.6 | 0.4 | 0.0 | |
| Age group | Total | Main diagnostic site | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | Nonrespiratory | Unknown | ||||||||
| PrimaryTable 11-3 - Footnote * | PulmonaryTable 11-3 - Footnote ** | Other respiratoryTable 11-3 - Footnote ^ | Miliary | CNS | Peripheral lymph nodes | OtherTable 11-3 - Footnote ^^ | ||||
|
||||||||||
| <1 | Cases | 9 | 1 | 6 | 0 | 0 | 0 | 1 | 1 | 0 |
| Rate | 2.4 | 0.3 | 1.6 | 0.0 | 0.0 | 0.0 | 0.3 | 0.3 | 0.0 | |
| 1-4 | Cases | 48 | 21 | 23 | 1 | 0 | 0 | 2 | 1 | 0 |
| Rate | 3.1 | 1.4 | 1.5 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | |
| 5-14 | Cases | 53 | 16 | 30 | 2 | 0 | 1 | 2 | 2 | 0 |
| Rate | 1.4 | 0.4 | 0.8 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | |
| 15-24 | Cases | 238 | 10 | 156 | 19 | 1 | 4 | 30 | 18 | 0 |
| Rate | 5.2 | 0.2 | 3.4 | 0.4 | 0.0 | 0.1 | 0.7 | 0.4 | 0.0 | |
| 25-34 | Cases | 294 | 3 | 191 | 21 | 1 | 5 | 52 | 21 | 0 |
| Rate | 6.1 | 0.1 | 3.9 | 0.4 | 0.0 | 0.1 | 1.1 | 0.4 | 0.0 | |
| 35-44 | Cases | 267 | 1 | 166 | 18 | 1 | 4 | 48 | 29 | 0 |
| Rate | 5.7 | 0.0 | 3.5 | 0.4 | 0.0 | 0.1 | 1.0 | 0.6 | 0.0 | |
| 45-54 | Cases | 233 | 3 | 165 | 9 | 1 | 3 | 31 | 21 | 0 |
| Rate | 4.3 | 0.1 | 3.1 | 0.2 | 0.0 | 0.1 | 0.6 | 0.4 | 0.0 | |
| 55-64 | Cases | 152 | 0 | 105 | 5 | 1 | 1 | 20 | 20 | 0 |
| Rate | 3.4 | 0.0 | 2.3 | 0.1 | 0.0 | 0.0 | 0.4 | 0.4 | 0.0 | |
| 65-74 | Cases | 177 | 2 | 132 | 10 | 2 | 2 | 6 | 23 | 0 |
| Rate | 6.2 | 0.1 | 4.7 | 0.4 | 0.1 | 0.1 | 0.2 | 0.8 | 0.0 | |
| 75+ | Cases | 214 | 2 | 164 | 12 | 1 | 1 | 12 | 22 | 0 |
| Rate | 9.1 | 0.1 | 7.0 | 0.5 | 0.0 | 0.0 | 0.5 | 0.9 | 0.0 | |
| TOTAL | Cases | 1,685 | 59 | 1,138 | 97 | 8 | 21 | 204 | 158 | 0 |
| Rate | 4.8 | 0.2 | 3.3 | 0.3 | 0.0 | 0.1 | 0.6 | 0.5 | 0.0 | |
| Origin | Total | Main diagnostic site | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | Non-respiratory | Unknown | ||||||||
| PrimaryTable 12-1 - Footnote * | PulmonaryTable 12-1 - Footnote ** | Other respiratoryTable 12-1 - Footnote ^ | Miliary | CNS | Peripheral lymph nodes | OtherTable 12-1 - Footnote ^^ | ||||
|
||||||||||
| Canadian-born | First Nations | 191 | 25 | 124 | 17 | 2 | 2 | 8 | 13 | 0 |
| First Nations with status | 188 | 25 | 121 | 17 | 2 | 2 | 8 | 13 | 0 | |
| First Nations with status - on reserve | 109 | 19 | 65 | 12 | 1 | 0 | 7 | 5 | 0 | |
| First Nations with status - off reserve |
73 | 6 | 51 | 5 | 1 | 1 | 1 | 8 | 0 | |
| First Nations with status - unknown |
6 | 0 | 5 | 0 | 0 | 1 | 0 | 0 | 0 | |
| First Nations, non-status | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Métis | 26 | 4 | 20 | 0 | 0 | 1 | 0 | 1 | 0 | |
| Inuit | 114 | 13 | 86 | 11 | 0 | 1 | 0 | 3 | 0 | |
| Total Aboriginal | 331 | 42 | 230 | 28 | 2 | 4 | 8 | 17 | 0 | |
| Non-Aboriginal | 185 | 12 | 130 | 11 | 3 | 2 | 10 | 17 | 0 | |
| Total Canadian-born | 516 | 54 | 360 | 39 | 5 | 6 | 18 | 34 | 0 | |
| Foreign-born (by epidemiological region) | AFR-High | 92 | 1 | 55 | 4 | 0 | 4 | 19 | 9 | 0 |
| AFR-Low | 28 | 0 | 19 | 1 | 0 | 1 | 4 | 3 | 0 | |
| AMR | 65 | 1 | 42 | 5 | 0 | 1 | 11 | 5 | 0 | |
| EEUR | 19 | 0 | 15 | 1 | 1 | 0 | 1 | 1 | 0 | |
| EME-CEUR | 56 | 0 | 41 | 12 | 1 | 0 | 1 | 1 | 0 | |
| EMR | 93 | 1 | 56 | 5 | 0 | 0 | 18 | 13 | 0 | |
| SEAR | 255 | 1 | 162 | 16 | 1 | 5 | 44 | 26 | 0 | |
| WPR | 433 | 5 | 275 | 17 | 3 | 7 | 75 | 51 | 0 | |
| Unknown | 14 | 0 | 8 | 2 | 0 | 0 | 3 | 1 | 0 | |
| Total Foreign-born | 1,055 | 9 | 673 | 63 | 6 | 18 | 176 | 110 | 0 | |
| Origin unknown | 16 | 0 | 9 | 0 | 0 | 0 | 4 | 3 | 0 | |
| TOTAL | 1,587 | 63 | 1,042 | 102 | 11 | 24 | 198 | 147 | 0 | |
| Origin | Total | Main diagnostic site | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | Non-respiratory | Unknown | ||||||||
| PrimaryTable 12-2 - Footnote * | PulmonaryTable 12-2 - Footnote ** | Other respiratoryTable 12-2 - Footnote ^ | Miliary | CNS | Peripheral lymph nodes | OtherTable 12-2 - Footnote ^^ | ||||
|
||||||||||
| Canadian-born | First Nations | 177 | 17 | 128 | 11 | 2 | 0 | 10 | 9 | 0 |
| First Nations with status | 174 | 17 | 126 | 11 | 2 | 0 | 9 | 9 | 0 | |
| First Nations with status - on reserve | 99 | 12 | 73 | 8 | 0 | 0 | 3 | 3 | 0 | |
| First Nations with status - off reserve |
69 | 5 | 50 | 3 | 1 | 0 | 5 | 5 | 0 | |
| First Nations with status - unknown |
6 | 0 | 3 | 0 | 1 | 0 | 1 | 1 | 0 | |
| First Nations, non-status | 3 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | |
| Métis | 21 | 3 | 14 | 1 | 1 | 0 | 1 | 1 | 0 | |
| Inuit | 105 | 6 | 92 | 3 | 0 | 0 | 0 | 4 | 0 | |
| Total Aboriginal | 303 | 26 | 234 | 15 | 3 | 0 | 11 | 14 | 0 | |
| Non-Aboriginal | 186 | 14 | 136 | 5 | 1 | 1 | 7 | 22 | 0 | |
| Total Canadian-born | 489 | 40 | 370 | 20 | 4 | 1 | 18 | 36 | 0 | |
| Foreign-born (by epidemiological region) | AFR-High | 108 | 3 | 64 | 11 | 0 | 3 | 16 | 11 | 0 |
| AFR-Low | 28 | 0 | 16 | 0 | 0 | 1 | 8 | 3 | 0 | |
| AMR | 67 | 0 | 38 | 4 | 2 | 2 | 11 | 10 | 0 | |
| EEUR | 17 | 0 | 14 | 1 | 1 | 0 | 1 | 0 | 0 | |
| EME-CEUR | 50 | 1 | 36 | 5 | 0 | 2 | 4 | 2 | 0 | |
| EMR | 108 | 0 | 58 | 6 | 1 | 2 | 25 | 16 | 0 | |
| SEAR | 273 | 1 | 172 | 19 | 2 | 6 | 60 | 13 | 0 | |
| WPR | 444 | 3 | 309 | 15 | 2 | 4 | 72 | 39 | 0 | |
| Unknown | 10 | 0 | 3 | 1 | 0 | 0 | 3 | 3 | 0 | |
| Total Foreign-born | 1,105 | 8 | 710 | 62 | 8 | 20 | 200 | 97 | 0 | |
| Origin unknown | 24 | 0 | 18 | 1 | 1 | 0 | 2 | 2 | 0 | |
| TOTAL | 1,618 | 48 | 1,098 | 83 | 13 | 21 | 220 | 135 | 0 | |
| Origin | Total | Main diagnostic site | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | Non-respiratory | Unknown | ||||||||
| PrimaryTable 12-3 - Footnote * | PulmonaryTable 12-3 - Footnote ** | Other respiratoryTable 12-3 - Footnote ^ | Miliary | CNS | Peripheral lymph nodes | OtherTable 12-3 - Footnote ^^ | ||||
|
||||||||||
| Canadian-born | First Nations | 208 | 20 | 148 | 19 | 0 | 4 | 4 | 13 | 0 |
| First Nations with status | 200 | 20 | 143 | 18 | 0 | 4 | 4 | 11 | 0 | |
| First Nations with status - on reserve | 113 | 13 | 85 | 10 | 0 | 0 | 1 | 4 | 0 | |
| First Nations with status - off reserve |
82 | 7 | 55 | 7 | 0 | 4 | 3 | 6 | 0 | |
| First Nations with status - unknown |
5 | 0 | 3 | 1 | 0 | 0 | 0 | 1 | 0 | |
| First Nations, non-status | 8 | 0 | 5 | 1 | 0 | 0 | 0 | 2 | 0 | |
| Métis | 11 | 1 | 8 | 1 | 0 | 0 | 1 | 0 | 0 | |
| Inuit | 160 | 12 | 139 | 7 | 0 | 0 | 0 | 2 | 0 | |
| Total Aboriginal | 379 | 33 | 295 | 27 | 0 | 4 | 5 | 15 | 0 | |
| Non-Aboriginal | 173 | 16 | 115 | 10 | 0 | 0 | 10 | 22 | 0 | |
| Total Canadian-born | 552 | 49 | 410 | 37 | 0 | 4 | 15 | 37 | 0 | |
| Foreign-born (by epidemiological region) | AFR-High | 103 | 2 | 64 | 6 | 2 | 3 | 14 | 12 | 0 |
| AFR-Low | 31 | 0 | 23 | 1 | 0 | 0 | 4 | 3 | 0 | |
| AMR | 50 | 0 | 38 | 2 | 0 | 1 | 4 | 5 | 0 | |
| EEUR | 14 | 0 | 13 | 0 | 0 | 0 | 1 | 0 | 0 | |
| EME-CEUR | 46 | 1 | 32 | 3 | 0 | 0 | 3 | 7 | 0 | |
| EMR | 116 | 1 | 62 | 5 | 1 | 3 | 26 | 18 | 0 | |
| SEAR | 270 | 4 | 162 | 18 | 1 | 4 | 50 | 31 | 0 | |
| WPR | 462 | 2 | 304 | 24 | 3 | 6 | 83 | 40 | 0 | |
| Unknown | 8 | 0 | 5 | 1 | 0 | 0 | 1 | 1 | 0 | |
| Total Foreign-born | 1,100 | 10 | 703 | 60 | 7 | 17 | 186 | 117 | 0 | |
| Origin unknown | 33 | 0 | 25 | 0 | 1 | 0 | 3 | 4 | 0 | |
| TOTAL | 1,685 | 59 | 1,138 | 97 | 8 | 21 | 204 | 158 | 0 | |
| Resistance pattern | Total | New active cases | Re-treatment cases | Unknown status | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aboriginal | Foreign-born | Non-Aboriginal | Unknown | Aboriginal | Foreign-born | Non-Aboriginal | Unknown | Aboriginal | Foreign-born | Non-Aboriginal | Unknown | ||
|
|||||||||||||
| Total positive culture | 1268 | 211 | 806 | 141 | 11 | 31 | 34 | 8 | 3 | 3 | 16 | 3 | 1 |
| Total positive culture with DST results | 1215 | 210 | 766 | 139 | 10 | 31 | 33 | 7 | 1 | 2 | 13 | 3 | 0 |
| Resistance pattern unknown | 53 | 1 | 40 | 2 | 1 | 0 | 1 | 1 | 2 | 1 | 3 | 0 | 1 |
| No resistance | 1103 | 202 | 685 | 126 | 10 | 30 | 27 | 6 | 0 | 2 | 12 | 3 | 0 |
| Resistance to one or more drugs | 112 | 8 | 81 | 13 | 0 | 1 | 6 | 1 | 1 | 0 | 1 | 0 | 0 |
| MONORESISTANCE | |||||||||||||
| Monoresistance: INH | 75 | 8 | 51 | 9 | 0 | 1 | 3 | 1 | 1 | 0 | 1 | 0 | 0 |
| Monoresistance: EMB | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Monoresistance: RMP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Monoresistance: PZA | 14 | 0 | 9 | 4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total monoresistance | 91 | 8 | 60 | 13 | 0 | 1 | 6 | 1 | 1 | 0 | 1 | 0 | 0 |
| MULTIDRUG-RESISTANT (MDR-TB)Table 18-1 - Footnote * | |||||||||||||
| INH & RMP | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH& RMP & PZA | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH& RMP & EMB | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH & RMP & EMB & PZA | 5 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total MDR | 13 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EXTENSIVELY DRUG-RESISTANT (XDR-TB)Table 18-1 - Footnote † | |||||||||||||
| INH & RMP & EMB & PZA & KM & OFL | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total XDR | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER PATTERNS | |||||||||||||
| INH & EMB & PZA | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH & EMB | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH & PZA | 4 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total other patterns | 7 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Resistance pattern | Total | New active cases | Re-treatment cases | Unknown status | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aboriginal | Foreign-born | Non-Aboriginal | Unknown | Aboriginal | Foreign-born | Non-Aboriginal | Unknown | Aboriginal | Foreign-born | Non-Aboriginal | Unknown | ||
|
|||||||||||||
| Total positive culture | 1334 | 210 | 873 | 131 | 9 | 36 | 48 | 4 | 0 | 4 | 6 | 5 | 8 |
| Total positive culture with DST results | 1280 | 208 | 835 | 123 | 9 | 35 | 46 | 4 | 0 | 1 | 6 | 5 | 8 |
| Resistance pattern unknown | 54 | 2 | 38 | 8 | 0 | 1 | 2 | 0 | 0 | 3 | 0 | 0 | 0 |
| No resistance | 1150 | 201 | 732 | 113 | 8 | 35 | 41 | 3 | 0 | 1 | 4 | 4 | 8 |
| Resistance to one or more drugs | 130 | 7 | 103 | 10 | 1 | 0 | 5 | 1 | 0 | 0 | 2 | 1 | 0 |
| MONORESISTANCE | |||||||||||||
| Monoresistance: INH | 96 | 7 | 79 | 8 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| Monoresistance: EMB | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Monoresistance: RMP | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Monoresistance: PZA | 15 | 0 | 10 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 0 |
| Total monoresistance | 113 | 7 | 90 | 10 | 1 | 0 | 1 | 1 | 0 | 0 | 2 | 1 | 0 |
| MULTIDRUG-RESISTANT (MDR-TB)Table 18-2 - Footnote * | |||||||||||||
| INH & RMP | 6 | 0 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH& RMP & PZA | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH& RMP & EMB | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH & RMP & EMB & PZA | 4 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total MDR | 15 | 0 | 12 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| EXTENSIVELY DRUG-RESISTANT (XDR-TB)Table 18-2 - Footnote † | |||||||||||||
| INH & RMP & EMB & PZA & KM & OFL | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total XDR | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER PATTERNS | |||||||||||||
| INH & EMB & PZA | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total other patterns | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Resistance pattern | Total | New active cases | Re-treatment cases | Unknown status | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aboriginal | Foreign-born | Non-Aboriginal | Unknown | Aboriginal | Foreign-born | Non-Aboriginal | Unknown | Aboriginal | Foreign-born | Non-Aboriginal | Unknown | ||
|
|||||||||||||
| Total positive culture | 1,367 | 280 | 860 | 118 | 24 | 25 | 35 | 5 | 1 | 0 | 11 | 5 | 3 |
| Total positive culture with DST results | 1,326 | 276 | 833 | 113 | 22 | 25 | 33 | 5 | 1 | 0 | 10 | 5 | 3 |
| Resistance pattern unknown | 41 | 4 | 27 | 5 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
| No resistance | 1,196 | 267 | 739 | 95 | 21 | 25 | 29 | 4 | 1 | 0 | 8 | 4 | 3 |
| Resistance to one or more drugs | 130 | 9 | 94 | 18 | 1 | 0 | 4 | 1 | 0 | 0 | 2 | 1 | 0 |
| MONORESISTANCE | |||||||||||||
| Monoresistance: INH | 95 | 9 | 69 | 11 | 1 | 0 | 3 | 1 | 0 | 0 | 1 | 0 | 0 |
| Monoresistance: EMB | 2 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Monoresistance: RMP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Monoresistance: PZA | 23 | 0 | 17 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total monoresistance | 120 | 9 | 87 | 17 | 1 | 0 | 3 | 1 | 0 | 0 | 1 | 1 | 0 |
| MULTIDRUG-RESISTANT (MDR-TB)Table 18-3 - Footnote * | |||||||||||||
| INH & RMP | 4 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| INH& RMP & PZA | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH & RMP & EMB & PZA | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total MDR | 8 | 0 | 6 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| EXTENSIVELY DRUG-RESISTANT (XDR-TB)Table 18-3 - Footnote † | |||||||||||||
| INH & RMP & EMB & PZA& KM & OFL & MOX & RBT & SM | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total XDR | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER PATTERNS | |||||||||||||
| INH & PZA | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total other patterns | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Treatment regimen | Total | Treatment outcome | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cure | Treatment completed without culture | Death before or during treatment | Transferred | Absconded | Treatment ongoing | Treatment discontinued due to adverse event | Failure | Other | Unknown | ||
|
|||||||||||
| INH-RMP-EMB-PZA | 424 | 54 | 334 | 13 | 9 | 6 | 2 | 2 | 0 | 4 | 0 |
| INH-RMP-PZA | 243 | 41 | 186 | 7 | 2 | 4 | 0 | 0 | 1 | 2 | 0 |
| INH-RMP-EMB-PZA-OTHER | 184 | 3 | 159 | 15 | 2 | 2 | 1 | 0 | 0 | 1 | 1 |
| INH-RMP | 84 | 8 | 70 | 0 | 0 | 1 | 2 | 0 | 0 | 3 | 0 |
| INH-RMP-PZA-OTHER | 80 | 12 | 56 | 7 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-RMP-OTHER | 65 | 5 | 48 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 7 |
| INH-RMP-EMB | 34 | 1 | 28 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 0 |
| INH-RMP-EMB-OTHER | 30 | 1 | 22 | 2 | 3 | 0 | 0 | 0 | 0 | 1 | 1 |
| INH-EMB-PZA-OTHER | 21 | 1 | 17 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB-OTHER | 11 | 3 | 5 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| OTHER | 10 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| RMP-EMB-PZA-OTHER | 10 | 2 | 6 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB-PZA | 9 | 0 | 8 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-OTHER | 9 | 1 | 7 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-EMB-OTHER | 7 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-PZA-OTHER | 7 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EMB-OTHER | 5 | 0 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| EMB-PZA-OTHER | 5 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| INH-OTHER | 5 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| RMP-EMB | 5 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-PZA-OTHER | 5 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| EMB | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| RMP-PZA | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EMB-PZA | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-EMB | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-EMB-PZA | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PZA-OTHER | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not reportedTable 23-1 - Footnote * | 391 | 0 | 303 | 73 | 5 | 2 | 1 | 0 | 1 | 3 | 3 |
| TOTAL | 1,655 | 136 | 1,297 | 128 | 32 | 17 | 6 | 3 | 3 | 18 | 15 |
| Treatment regimen | Total | Treatment outcome | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cure | Treatment completed without culture | Death before or during treatment | Transferred | Absconded | Treatment ongoing | Treatment discontinued due to adverse event | Failure | Other | Unknown | ||
|
|||||||||||
| INH-RMP-EMB-PZA | 461 | 84 | 344 | 15 | 6 | 4 | 5 | 0 | 0 | 1 | 2 |
| INH-RMP-PZA | 182 | 19 | 153 | 5 | 2 | 1 | 0 | 0 | 1 | 0 | 1 |
| INH-RMP | 104 | 41 | 53 | 5 | 2 | 1 | 1 | 0 | 0 | 0 | 1 |
| INH-RMP-EMB | 49 | 17 | 23 | 1 | 0 | 2 | 3 | 0 | 0 | 0 | 3 |
| INH-RMP-EMB-PZA-OTHER | 39 | 13 | 22 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| INH-RMP-PZA-OTHER | 22 | 8 | 13 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB-PZA | 8 | 1 | 6 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-RMP-EMB-OTHER | 7 | 2 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| INH-EMB-PZA-OTHER | 6 | 1 | 3 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| EMB-OTHER | 5 | 1 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB | 5 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB-OTHER | 4 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| INH-EMB-PZA | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-RMP-OTHER | 3 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB-PZA-OTHER | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-PZA-OTHER | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EMB-PZA-OTHER | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| INH-EMB-OTHER | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-OTHER | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EMB | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-EMB | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-OTHER | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-PZA | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not reportedTable 23-2 - Footnote * | 672 | 0 | 556 | 88 | 7 | 3 | 1 | 6 | 0 | 4 | 7 |
| TOTAL | 1,587 | 192 | 1,199 | 122 | 21 | 12 | 11 | 9 | 1 | 6 | 14 |
| Treatment regimen | Total | Treatment outcome | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cure | Treatment completed without culture | Death during treatment | Transferred | Absconded | Treatment ongoing | Treatment discontinued due to adverse event | Failure | Other | Unknown | ||
|
|||||||||||
| INH-RMP-EMB-PZA | 467 | 95 | 230 | 21 | 4 | 3 | 0 | 3 | 0 | 2 | 109 |
| INH-RMP-PZA | 221 | 37 | 149 | 10 | 7 | 0 | 0 | 0 | 0 | 1 | 17 |
| INH-RMP | 50 | 6 | 34 | 4 | 1 | 0 | 0 | 0 | 0 | 3 | 2 |
| INH-RMP-EMB-PZA-OTHER | 48 | 11 | 33 | 3 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| INH-RMP-EMB | 43 | 6 | 25 | 4 | 1 | 1 | 0 | 0 | 0 | 1 | 5 |
| INH-RMP-PZA-OTHER | 18 | 5 | 12 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| RMP-EMB-PZA | 12 | 0 | 9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| INH-RMP-EMB-OTHER | 10 | 1 | 7 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-EMB-PZA-OTHER | 7 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB-PZA-OTHER | 7 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-EMB-PZA | 4 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| INH-EMB-OTHER | 3 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-PZA-OTHER | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-RMP-OTHER | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EMB-PZA-OTHER | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB-OTHER | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EMB-OTHER | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| INH-PZA | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| PZA-OTHER | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RMP-EMB | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| RMP-PZA-OTHER | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not reportedTable 23-3 - Footnote * | 712 | 2 | 559 | 92 | 17 | 2 | 12 | 1 | 0 | 5 | 22 |
| TOTAL | 1,618 | 166 | 1,085 | 140 | 31 | 7 | 14 | 4 | 0 | 12 | 159 |
| Cause of death | Canada | Province/territory | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent of total cases reported for year | N.L. | P.E.I. | N.S. | N.B. | Que. | Ont. | Man. | Sask. | Alta. | B.C. | Y.T. | N.W.T. | Nvt. | |
| Cases reported in 2009 who died before or during treatmentTable 26 - Footnote * | |||||||||||||||
| TB was the cause of death | 20 | 1.2 | 0 | 0 | 0 | 0 | 2 | 11 | 1 | 0 | 2 | 3 | 0 | 0 | 1 |
| TB contributed to death but was not the underlying cause | 63 | 3.8 | 0 | 0 | 0 | 1 | 9 | 23 | 1 | 6 | 6 | 14 | 0 | 2 | 1 |
| TB did not contribute to death but was an incidental finding | 45 | 2.7 | 0 | 0 | 0 | 0 | 6 | 15 | 8 | 0 | 6 | 10 | 0 | 0 | 0 |
| Unknown | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TOTAL | 128 | 7.7 | 0 | 0 | 0 | 1 | 17 | 49 | 10 | 6 | 14 | 27 | 0 | 2 | 2 |
| Cases reported in 2010 who died before or during treatment | |||||||||||||||
| TB was the cause of death | 31 | 2.0 | 0 | 0 | 0 | 0 | 2 | 18 | 0 | 1 | 0 | 9 | 0 | 1 | 0 |
| TB contributed to death but was not the underlying cause | 38 | 2.4 | 0 | 0 | 1 | 0 | 5 | 15 | 2 | 4 | 2 | 9 | 0 | 0 | 0 |
| TB did not contribute to death but was an incidental finding | 43 | 2.7 | 0 | 0 | 1 | 1 | 3 | 21 | 3 | 1 | 3 | 8 | 1 | 0 | 1 |
| Unknown | 10 | 0.6 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TOTAL | 122 | 7.7 | 0 | 0 | 2 | 1 | 10 | 64 | 5 | 6 | 5 | 26 | 1 | 1 | 1 |
| Cases reported in 2011 who died before or during treatment | |||||||||||||||
| TB was the cause of death | 35 | 2.2 | 0 | 0 | 0 | 0 | 2 | 19 | 2 | 0 | 3 | 8 | 0 | 1 | 0 |
| TB contributed to death but was not the underlying cause | 69 | 4.3 | 0 | 0 | 0 | 0 | 4 | 20 | 8 | 11 | 7 | 18 | 0 | 0 | 1 |
| TB did not contribute to death but was an incidental finding | 29 | 1.8 | 1 | 0 | 1 | 0 | 6 | 9 | 1 | 1 | 1 | 8 | 0 | 1 | 0 |
| Unknown | 7 | 0.4 | 0 | 0 | 0 | 0 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TOTAL | 140 | 8.7 | 1 | 0 | 1 | 0 | 13 | 54 | 11 | 12 | 11 | 34 | 0 | 2 | 1 |
| Cases reported in 2012 who died before or during treatmentTable 26 - Footnote ** | |||||||||||||||
| TB was the cause of death | 22 | 1.3 | 0 | 0 | 0 | 0 | 3 | 10 | 2 | 0 | 0 | 7 | 0 | 0 | 0 |
| TB contributed to death but was not the underlying cause | 50 | 3.0 | 1 | 0 | 0 | 0 | 7 | 17 | 2 | 4 | 8 | 10 | 0 | 1 | 0 |
| TB did not contribute to death but was an incidental finding | 39 | 2.3 | 0 | 0 | 0 | 0 | 4 | 12 | 1 | 1 | 4 | 17 | 0 | 0 | 0 |
| Unknown | 5 | 0.3 | 0 | 0 | 0 | 1 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TOTAL | 116 | 6.9 | 1 | 0 | 0 | 1 | 14 | 43 | 5 | 5 | 12 | 34 | 0 | 1 | 0 |
| Sex | Total | Age group | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1-4 | 5-14 | 15-24 | 25-34 | 35-44 | 45-54 | 55-64 | 65-74 | 75+ | ||
| Cases reported in 2009 who died before or during treatmentTable 27 - Footnote * | |||||||||||
| Male | 83 | 0 | 0 | 0 | 1 | 4 | 2 | 14 | 11 | 12 | 39 |
| Female | 45 | 0 | 0 | 0 | 0 | 1 | 3 | 6 | 9 | 8 | 18 |
| TOTAL | 128 | 0 | 0 | 0 | 1 | 5 | 5 | 20 | 20 | 20 | 57 |
| Cases reported in 2010 who died before or during treatment | |||||||||||
| Male | 72 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 11 | 15 | 38 |
| Female | 50 | 0 | 1 | 0 | 1 | 3 | 0 | 7 | 7 | 8 | 23 |
| TOTAL | 122 | 0 | 1 | 0 | 1 | 3 | 2 | 13 | 18 | 23 | 61 |
| Cases reported in 2011 who died before or during treatment | |||||||||||
| Male | 93 | 1 | 0 | 0 | 1 | 5 | 5 | 6 | 12 | 14 | 49 |
| Female | 47 | 0 | 0 | 0 | 0 | 3 | 4 | 6 | 5 | 7 | 22 |
| TOTAL | 140 | 1 | 0 | 0 | 1 | 8 | 9 | 12 | 17 | 21 | 71 |
| Cases reported in 2012 who died before or during treatmentTable 27 - Footnote ** | |||||||||||
| Male | 83 | 0 | 0 | 0 | 2 | 3 | 4 | 8 | 11 | 12 | 43 |
| Female | 33 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 4 | 9 | 15 |
| TOTAL | 116 | 0 | 0 | 0 | 2 | 5 | 5 | 10 | 15 | 21 | 58 |
Page details
- Date modified: